-
1
المؤلفون: Clemens, Eva, Van den Heuvel - Eibrink, Marry, Mulder, RL, Kremer, LCM (Leontien), Hudson, MM, Skinner, R, Constine, LS, Bass, JK, Kuehni, CE, Langer, T, van Dalen, EC, Bardi, E, Bonne, NX, Brock, PR, Brooks, B, Carleton, B, Caron, E, Chang, KW, Johnston, K, Knight, K, Nathan, PC, Orgel, E, Prasad, PK, Rottenberg, J, Scheinemann, K, de Vries, A.C.H., Walwyn, T, Weiss, A, Zehnhoff-Dinnesen, AA, Cohn, RJ, Landier, W, Kadan-Lottick, N, Levitt, G, Hoetink, A, Mussman, J
المساهمون: Princess Máxima Center for Pediatric Oncology [Utrecht, Netherlands], Erasmus MC-Sophia Hospital [Rotterdam, Netherlands], Emma Children's Hospital [Amsterdam, Netherlands] (Academic Medical Center), University of Amsterdam [Amsterdam] (UvA), St Jude Children's Research Hospital, Great North Children’s Hospital [Newcastle Upon Tyne, UK], Northern Institute for Cancer Research [Newcastle] (NICR), Newcastle University [Newcastle], University of Rochester Medical Center (URMC), Institute of Social and Preventive Medicine [Bern] (ISPM), Universität Bern [Bern] (UNIBE), University Hospital for Children and Adolescents [Lübeck, Germany], Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 (PRISM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service d'Otologie et d'Otoneurologie [CHU Lille], Centre Hospitalier Universitaire de Lille (CHU de Lille), Great Ormond Street Hospital for Children NHS Foundation Trust [London, UK] (GOSHC), University of British Columbia (UBC), Stanford University, Sydney Children's hospital, Oregon Health and Science University [Portland] (OHSU), The Hospital for sick children [Toronto] (SickKids), Children’s Hospital Los Angeles [Los Angeles], University of Southern California (USC), Louisiana State University (LSU), Children's Hospital at New Orleans, Masaryk University [Brno] (MUNI), Kantonsspital Aarau [Aarau, Switzerland], University Hospital Basel [Basel], McMaster University [Hamilton, Ontario], Perth Children's Hospital [Nedlands, WA, Australia], The University of Western Australia (UWA), University of Regensburg, University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), University of New South Wales [Sydney] (UNSW), University of Alabama at Birmingham [ Birmingham] (UAB), SALZET, Michel, Pediatrics, Universität Bern [Bern], Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Great Ormond Street Hospital for Children NHS Foundation Trust [London, UK]
المصدر: Lancet Oncology
Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩
Lancet Oncol
Lancet Oncology, 20(1), E29-E41. Lancet Publishing Group
The Lancet Oncology
The Lancet Oncology, 2019, 20 (1), pp.e29-e41. ⟨10.1016/S1470-2045(18)30858-1⟩مصطلحات موضوعية: Shunt placement, Pediatrics, medicine.medical_specialty, Adolescent, [SDV]Life Sciences [q-bio], Childhood cancer, Harmonization, Antineoplastic Agents, Platinum Compounds, Article, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Ototoxicity, SDG 3 - Good Health and Well-being, Cancer Survivors, Neoplasms, otorhinolaryngologic diseases, Medicine, Humans, Young adult, 030223 otorhinolaryngology, Child, Evidence-Based Medicine, business.industry, Cancer, Guideline, medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], Oncology, 030220 oncology & carcinogenesis, Population Surveillance, Cranial Irradiation, business, Delivery of Health Care
-
2
المؤلفون: Feijen, EAM, Font-Gonzalez, A, van der Pal, HJH, Kok, WEM, Geskus, RB, Ronckers, CM, Bresters, D, van Dalen, EC, van Dulmen-den Broeder, E, van den Berg, MH, te Loo, M, Van den Heuvel - Eibrink, Marry, van Leeuwen, FE, Loonen, JJ, Neggers, S.J.C.M.M., Versluys, ABB, Tissing, WJE, Kremer, LCM (Leontien), Dolsma, W, Grootenhuis, MA, den Hartogh, JG, Jaspers, MWM, Postma, A, Hollema, N, Kok, JL, Teepen, JC, Ridder, JG, Caron, HN, Meer, P
المساهمون: Pediatric surgery, CCA - Cancer Treatment and quality of life, Amsterdam Reproduction & Development (AR&D), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Cardiovascular Centre (CVC), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), Internal Medicine, Paediatric Oncology, ARD - Amsterdam Reproduction and Development, CCA - Cancer Treatment and Quality of Life, ACS - Heart failure & arrhythmias
المصدر: Journal of the American Heart Association, 8(1). Wiley-Blackwell
Journal of the American Heart Association, 8(1):009122. Wiley
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 8, 1
Feijen, E A M L, Font-Gonzalez, A, van der Pal, H J H, Kok, W E M, Geskus, R B, Ronckers, C C M, Bresters, D, van Dalen, E C, van Dulmen-den Broeder, E, van den Berg, M H, van der Heiden-van der Loo, M, van den Heuvel-Eibrink, M M, van Leeuwen, F E, Loonen, J J, Neggers, S J C M M, Versluys, A B B, Tissing, W J E, Kremer, L C M, DCOG-LATER Study Group, Dolsma, W V, Grootenhuis, M A, den Hartogh, J, Jaspers, M W M, Hollema, N, Kok, J L, Teepen, J C, de Ridder-Sluiter, J G, Caron, H N & van der Meer, P 2019, ' Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study ', Journal of the American Heart Association, vol. 8, no. 1, pp. e009122 . https://doi.org/10.1161/JAHA.118.009122
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 8
Journal of the American Heart Association, 8(1):e009122. Wiley
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, 8(1):e009122. Wiley-Blackwellمصطلحات موضوعية: Male, Pediatrics, Epidemiology, medicine.medical_treatment, heart failure, CUMULATIVE INCIDENCE, CHILDREN, 030204 cardiovascular system & hematology, DOXORUBICIN THERAPY, 0302 clinical medicine, Cancer Survivors, Risk Factors, Neoplasms, Cardiovascular Disease, Cumulative incidence, Child, Netherlands, Original Research, Incidence, Middle Aged, 3. Good health, MITOXANTRONE, Survival Rate, 030220 oncology & carcinogenesis, Cohort, HEALTH OUTCOMES, Female, Cardiology and Cardiovascular Medicine, medicine.drug, Adult, CARDIOTOXICITY, medicine.medical_specialty, Cyclophosphamide, Adolescent, childhood cancer survivors, LATE MORTALITY, Childhood cancer, Risk Assessment, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], 03 medical and health sciences, Young Adult, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, medicine, Humans, Aged, Retrospective Studies, Mitoxantrone, Cardiotoxicity, business.industry, medicine.disease, Radiation therapy, Heart failure, business, Follow-Up Studies, Forecasting
وصف الملف: application/pdf
-
3دورية أكاديمية
المؤلفون: Feijen, EAM, van der Pal, HJ, van Dalen, EC, Tissing, WJE, Kremer, LCM
المصدر: Tijdschrift voor Kindergeneeskunde. February 2013 81(1):40-40
-
4
المؤلفون: van Dalen, EC, Michiels, Erna, Caron, HN, Kremer, LCM (Leontien)
المساهمون: Pediatrics
المصدر: Cochrane Database Systematics Review, 12(5). John Wiley & Sons Ltd.
مصطلحات موضوعية: SDG 3 - Good Health and Well-being
URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::ad54f0fcf74ff0ca6742065552eab69c
https://pure.eur.nl/en/publications/89f2aa03-e5b8-4bec-a438-cbcfcc84015d -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.